CTLA4 and colon carcinoma: The administration of anti‐CTLA‐4 antibody after injecting cyclophosphamide significantly inhibits the tumor progression in the CT26 colon carcinoma model, while the reverse administration sequence leads to the apoptosis of anti-tumor CD8+ T cells (130).